Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Marc Fisher, MD, Beth Israel Deaconess Medical Center, Boston, MA, discusses the current state of neuroprotection for stroke treatment, highlighting the shift towards combining neuroprotection with thrombectomy as a potential proof of concept. Prof. Fisher discusses positive trial results from China, but expresses caution regarding the interpretation of these results. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.